ArticleGastroenterology report2020

Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth.

Guermarie Velazquez-Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.